Atazanavir Sulfate/Ritonavir/Lamivudine/Zidovudine

硫酸阿扎那韦/利托那韦/拉米夫定/齐多夫定

Report date: 2024/04/24 16:50:19

Base Information

Drug NameAtazanavir Sulfate/Ritonavir/Lamivudine/Zidovudine
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionHuman immunodeficiency virus type 1 protease inhibitorsReverse transcriptase inhibitorsHuman immunodeficiency virus type 1 reverse transcriptase inhibitors
TargetsHuman immunodeficiency virus type 1 proteaseReverse transcriptaseHuman immunodeficiency virus type 1 reverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsHIV Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2014/09/04
Country/TerritoryUnited States
CombinationsYes Atazanavir SulfateRitonavirLamivudine
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMylan Laboratories Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMylan Laboratories Ltd
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A